Private company

ARCH Venture Fund VIII, L.P.

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

ARCH Venture Fund VIII, L.P. sits at the top of its group. 5 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

ARCH Venture Fund VIII, L.P. DE
- Codiak BioSciences, Inc. Stake · Cambridge, Massachusetts, United States
- Denali Therapeutics Inc. Stake · South San Francisco, California, United States
- Q32 Bio Inc. Stake · Waltham, Massachusetts
- Scholar Rock Holding Corp Stake · Cambridge, Massachusetts, United States

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.

Stakes it holds

ARCH Venture Fund VIII, L.P. has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).

Q32 Bio Inc.SC 13G/A May 13, 2024²
Scholar Rock Holding CorpSC 13G/A Feb 14, 2024³
Codiak BioSciences, Inc.SC 13D Sep 20, 2022⁴
Denali Therapeutics Inc.SC 13G/A Feb 8, 2022⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARARCH Venture Fund VIII, L.P. filings on SEC EDGAR
2
SEC EDGARARCH Venture Fund VIII, L.P. SC 13G/A on Q32 Bio Inc.
3
SEC EDGARARCH Venture Fund VIII, L.P. SC 13G/A on Scholar Rock Holding Corp
4
SEC EDGARARCH Venture Fund VIII, L.P. SC 13D on Codiak BioSciences, Inc.
5
SEC EDGARARCH Venture Fund VIII, L.P. SC 13G/A on Denali Therapeutics Inc.